Expert Review of Vaccines

HIV vaccine development: the myth of Sisyphus modernized?
pp. 879-882(4)
Author: Ljungberg, Karl

Balancing the benefits and risks of a botulinum toxin vaccine
pp. 883-886(4)
Author: Simpson, Lance L

Fully synthetic cancer vaccine shows promising results in mice
pp. 887-889(3)

Promising results from a Phase I trial with GeoVax's HIV vaccines
pp. 890-890(1)

Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine
pp. 891-902(12)
Author: Beran, Jiri

Status of malaria vaccine R&D in 2007
pp. 903-905(3)
Authors: Doolan, Denise L; Stewart, V Ann

Therapeutic vaccine for melanoma: the untouched grail?
pp. 907-911(5)
Authors: Ding, ZhenYu; Wei, YuQuan

Recombinant lentivector as a genetic immunization vehicle for antitumor immunity
pp. 913-924(12)
Authors: He, Yukai; Munn, David; Falo Jr, Louis D

Tissue vaccines for cancer
pp. 925-937(13)
Authors: Suckow, Mark A; Heinrich, Julie; Rosen, Elliot D

Epitope-based vaccine against influenza
pp. 939-948(10)
Authors: Ben-Yedidia, Tamar; Arnon, Ruth

Current progress of adhesins as vaccine candidates for Moraxella catarrhalis
pp. 949-956(8)
Authors: Tan, Thuan Tong; Riesbeck, Kristian

Application of carbohydrate array technology to antigen discovery and vaccine development
pp. 957-969(13)
Authors: Oyelaran, Oyindasola; Gildersleeve, Jeffrey C

Targeting intracellular signaling: a novel approach to vaccination
pp. 971-980(10)
Authors: Wales, Jeremy; Foxwell, Brian; Feldmann, Marc

Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics
pp. 981-990(10)
Authors: Jacobson, Sheldon H; Sewell, Edward C; Jokela, Janet A

Allergy vaccines: dreams and reality
pp. 991-999(9)
Author: Crameri, Reto

Development of biologicals for the therapy of lupus erythematosus
pp. 1001-1011(11)
Authors: Neumann, Detlef; Tschernig, Thomas; Boraschi, Diana

Corrigendum
pp. 1022-1022(1)